State Street Corp Has $3.05 Billion Stock Position in HCA Healthcare, Inc. $HCA

10 Dec 2025, 06:43 by Amy Steele · The Cerbat Gem

State Street Corp reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 2.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,956,663 shares of the company’s stock after selling 191,043 shares during the period. State Street Corp’s holdings in HCA Healthcare were worth $3,048,198,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in HCA. Brighton Jones LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth about $1,021,000. Zions Bancorporation National Association UT bought a new stake in shares of HCA Healthcare in the first quarter valued at about $98,000. Townsquare Capital LLC increased its position in HCA Healthcare by 24.2% during the first quarter. Townsquare Capital LLC now owns 3,117 shares of the company’s stock worth $1,077,000 after acquiring an additional 607 shares during the period. King Luther Capital Management Corp acquired a new position in shares of HCA Healthcare during the 1st quarter worth approximately $207,000. Finally, Independent Advisor Alliance raised its position in shares of HCA Healthcare by 32.9% in the first quarter. Independent Advisor Alliance now owns 2,612 shares of the company’s stock valued at $902,000 after buying an additional 647 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on HCA. The Goldman Sachs Group upped their target price on HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Jefferies Financial Group upped their price objective on HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. Truist Financial boosted their target price on HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Sanford C. Bernstein restated a “market perform” rating and issued a $417.00 price target on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, KeyCorp increased their price objective on shares of HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a research note on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $474.53.

Get Our Latest Report on HCA

Insider Activity

In related news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by company insiders.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $488.44 on Wednesday. The business has a 50 day moving average of $462.50 and a 200-day moving average of $411.98. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $520.00. The company has a market capitalization of $111.46 billion, a P/E ratio of 18.88, a P/E/G ratio of 1.43 and a beta of 1.36.

HCA Healthcare (NYSE:HCA – Get Free Report) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s payout ratio is 11.13%.

About HCA Healthcare

(Free Report)